Lptx stock earnings

(LPTX) Company Bio. Leap Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in acquiring and developing therapeutics in cancer biology. (NASDAQ:LPTX) has 17 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These 

LPTX: Leap Therapeutics, Inc. - Earnings Announcements. Stay up to date with lastest Earnings Announcements for Leap Therapeutics, Inc. from Zacks Investment Research LPTX:NASDAQ GM Stock Quote - Leap Therapeutics Inc ... Stock analysis for Leap Therapeutics Inc (LPTX:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. LPTX | Leap Therapeutics Inc. Stock Price & News - WSJ View the latest Leap Therapeutics Inc. (LPTX) stock price, news, historical charts, analyst ratings and financial information from WSJ. LEAP THERAPEUTICS, INC. (LPTX) Income Statement - … Income Statement for LEAP THERAPEUTICS, INC. (LPTX) - view income statements, balance sheet, cash flow, and key financial ratios for LEAP THERAPEUTICS, …

Ideas and Forecasts on LEAP THERAPEUTICS INC — …

Leap Therapeutics last announced its quarterly earnings results on March 16th, 2020. The reported ($0.33) EPS for the quarter, missing analysts' consensus  Find the latest and the upcoming Leap Therapeutics earnings report Mar 27, 2020 as well as EPS Forecast and LPTX top analyst price target The TipRanks Smart Score analyzes stocks based on 8 factors extracted from our unique datasets. Leap Therapeutics Inc (NASDAQ:LPTX) The current consensus among 4 polled investment analysts is to Buy stock in Leap Earnings and Sales Forecasts  LPTX: Leap Therapeutics, Inc. - Earnings Announcements. Stay up to date with lastest Earnings View All Zacks #1 Ranked Stocks. Trades from $1. The Zacks   Get the latest Leap Therapeutics, Inc. LPTX detailed stock quotes, stock data, Exp Earnings Date, 5/20/20 LPTX: What are Zacks experts saying now? Find the latest Leap Therapeutics, Inc. (LPTX) stock quote, history, news and other vital information to help you with your stock Earnings Date, Mar 16, 2020.

LPTX | Leap Therapeutics Inc. Analyst Estimates | MarketWatch

Leap Therapeutics, Inc. (LPTX) Analyst Ratings, Estimates ...

Leap Therapeutics, Inc. (LPTX) latest earnings report: revenue, EPS, surprise, history, news and analysis.

Investors | Leap Therapeutics, Inc. The Investor Relations website contains information about Leap Therapeutics, Inc.'s business for stockholders, potential investors, and financial analysts. LPTX Stock Price Quote & News - Leap Therapeutics | Robinhood View the real-time LPTX price chart on Robinhood and decide if you want to buy or sell commission-free. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Leap Therapeutics against related stocks people have also bought like TTNP, ONTX, VSTM, and ADXS. 1,353 people own Leap Therapeutics on Robinhood on April 3, 2020.

5 Feb 2020 General Motors earned a nickel a share during the fourth quarter of 2019, a little better than Wall Street expected.

LPTX's NASDAQ Last Sale (NLS) "Last Sale" is the price at which a stock last traded during regular market hours. NLS Volume "Volume" is the number of shares of the stock traded on the listing exchange during regular trading hours. Previous Close Today's High / Low 52 Week High / Low Leap Therapeutics Inc. (LPTX) Earnings Find stock price reaction to earnings announcements for Leap Therapeutics Inc. (LPTX). Table displays both upcoming quarterly earnings dates and historical release dates as well as stock price changes, if available. For stocks that list options, compare implied volatility before and after earnings dates, as well as the option market's expected versus actual price movement. LPTX Stock Price and Chart — NASDAQ:LPTX — TradingView Leap Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel therapies designed to treat patients with cancer. Its clinical stage programs are DKN-01, which is a monoclonal antibody that inhibits Dickkopf-related protein 1, or DKK1 and TRX518, which is a monoclonal antibody targeting the Investors | Leap Therapeutics, Inc. The Investor Relations website contains information about Leap Therapeutics, Inc.'s business for stockholders, potential investors, and financial analysts.

5 Feb 2020 General Motors earned a nickel a share during the fourth quarter of 2019, a little better than Wall Street expected. 19 Feb 2020 InMode earnings and sales beat expectations on Tuesday, but shares of INMD stock went into a two-day slide following the report. Leap Therapeutics, Inc. Common Stock (LPTX) Earnings ... Find the latest Earnings Report Date for Leap Therapeutics, Inc. Common Stock (LPTX) at Nasdaq.com. Leap Therapeutics, Inc. Common Stock (LPTX) Stock Quotes ...